FIELD: medicine.
SUBSTANCE: method involves introducing human fetus liver cells suspension containing stem cells, into patient liver and/or in pareneteral way. The suspension is introduced under ultrasonic control in the amount of 200-300 millions of cells under hepatic capsule at a depth of 0.5-1.0 cm. Being intravenously introduced, the dose is equal to 1.0-1.5 billions of cells. When combining both introduction methods, the total dose does not exceed 1.5 billions of cells.
EFFECT: stable restoration of kidney functions.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING THE CASES OF CHRONIC DIFFUSE HEPATIC DISEASES | 2004 |
|
RU2283113C2 |
| METHOD FOR RECOVERING BIOCHEMICAL INDICES OF PERIPHERAL BLOOD OF LABORATORY ANIMALS WITH TOXIC HEPATITIS | 2020 |
|
RU2739855C1 |
| METHOD FOR MAINTENANCE OF FUNCTIONAL STATE OF CIRRORTICALLY CHANGED LIVER IN PATIENTS IN WAITING LIST OF ORGAN TRANSPLANTATION | 2018 |
|
RU2682874C1 |
| BIOTRANSPLANT, TREATMENT METHOD OF CHRONIC LIVER DISEASES AND TREATMENT METHOD OF LIVER CIRRHOSIS AND PORTAL HYPERTENSION | 2007 |
|
RU2368384C2 |
| CELL PRODUCT FOR TREATING AND CORRECTING HEPATIC IMPAIRMENT | 2012 |
|
RU2510833C1 |
| RADIONUCLIDE METHOD FOR DETERMINING LIVER DYSFUNCTION AFTER ORTHOTOPIC TRANSPLANTATION | 2019 |
|
RU2718294C1 |
| METHOD FOR SEQUENTIAL ASSESSMENT OF RECIPIENT'S STATE FOLLOWING CADAVERIC LIVER TRANSPLANTATION | 2012 |
|
RU2494404C1 |
| BIOTRANSPLANT, METHOD FOR ITS PREPARING AND METHOD FOR TREATMENT OF CHRONIC HEPATITIS AND LIVER CIRRHOSIS (VARIANTS) | 2004 |
|
RU2272638C1 |
| METHOD FOR RECOVERING BIOCHEMICAL PARAMETERS OF PERIPHERAL BLOOD OF LABORATORY ANIMALS WITH HEPATIC CIRRHOSIS | 2019 |
|
RU2729931C1 |
| METHOD FOR TREATING CHRONIC HEPATITIS | 2005 |
|
RU2282457C1 |
